Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Transtec provides a safe alternative in opioid treatment

Feb. 4, 2008

Genetic variation in drug transporter ABCB1 is linked to antidepressant efficacy

Feb. 4, 2008

Further data on pregabalin efficacy in generalized anxiety disorder reported

Feb. 4, 2008

GlaxoSmithKline obtains approval for Amerge in Japan

Feb. 1, 2008

Somaxon submits NDA for Silenor, a drug candidate for insomnia therapy

Feb. 1, 2008

FDA issues nonapprovable letter to Impax for Vadova for Parkinson's disease

Feb. 1, 2008

New agents for treating neurological disorders described in recent patent literature

Feb. 1, 2008

Responses to nemifitide seen in patients with severe, refractory depression

Feb. 1, 2008

BTG commences first clinical study of novel migraine treatment

Jan. 31, 2008

Acorda Therapeutics announces successful QT study of Fampridine-SR

Jan. 30, 2008

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...